 |
|
|
|
 |
|
|
| Article 1 to 3 out of 3 concerning Ranbaxy Laboratories Ltd.
|
-
Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
(08 Aug 2008)
Cipher Pharmaceuticals Inc. announced that it has entered into a definitive development, distribution and supply agreement with Ranbaxy Pharmaceuticals Inc. ("RPI"), a wholly owned subsidiary of Ranbaxy Laboratories Limited, under which Cipher has ...
-
Ranbaxy to Bring in Daiichi Sankyo as Majority Partner
(13 Jun 2008)
Daiichi Sankyo Company, Limited and Ranbaxy Laboratories Limited announced that a binding Share Purchase and Share Subscription Agreement (the "SPSSA") was entered into between Daiichi Sankyo, Ranbaxy and the Singh family, the largest and ...
-
Gilead Announces Generic Viriad Licensing Agreements with Eight India-Based Companies
(26 Sep 2006)
Gilead Sciences, Inc. announced that the company has signed eight new non-exclusive license agreements with generic companies in India. These licensing agreements grant to Alkem Laboratories Ltd., Aurobindo Pharma Ltd., FDC Ltd., J.B. Chemicals & ...
|
|
|
|
|
Top
